« Back
Home /
Ocrelizumab (MS4A1/CD20) Antibody, Monoclonal

Ocrelizumab (MS4A1/CD20) Antibody, Monoclonal

Item no.	PRS-10-249-0.1mg
Manufacturer	ProSci
Amount	0.1 mg
Category	Oncology Antibodies Primary Antibodies By Organ Bladder Cancer Gastric Cancer
Type	Antibody Monoclonal
Specific against	other
Isotype	IgG1
Conjugate/Tag	Unconjugated
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	2H7
Available
Manufacturer - Isotype	IgG1-nd
Shipping Temperature	blue ice or room temperature
Storage Conditions	Store at -80°C
Manufacturer - Research Area	Drug Analogues
Background	Ocrelizumab is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis. It is a second-generation recombinant humanized monoclonal IgG1 antibody that selectively targets the B lymphocytes that express the CD20 antigen. As a humanized molecule, ocrelizumab is expected to be less immunogenic with repeated infusions which improves the benefit-to-risk profile for patients with relapsing or progressive forms of MS.
Purification	>95%
Buffer	PBS buffer pH7.5
Immunogen	Humanized / MS4A1/CD20 [Homo sapiens]
Clonality	Monoclonal
NCBI Organism	homo sapiens
Disclaimer	Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.1 mg

available

Delivery expected until 9/4/2025

Express Delivery: Save 22 days

Compare

Add to wishlist

Get an offer